# CVM GFI #119 How CVM Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-119-how-cvm-intends-to-handle-deficient-submissions-filed-during-the-investigation-of-a-new-animal-drug/1b8e8657-1290-49ce-9cc3-89d1651ee37b

> FDA guidance document: CVM GFI #119 How CVM Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug. Issue date: August 29, 2002. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #119 How CVM Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2002-08-29
- Last Changed: 2019-04-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0011">FDA-2001-D-0011</a>

## Related Documents

- [CVM GFI #173 Animal Drug Sponsor Fees Under the Animal Drug User Fee Act (ADUFA)](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-173-animal-drug-sponsor-fees-under-the-animal-drug-user-fee-act-adufa/6beb2f98-c619-4746-bf98-be24fb8c2734)
- [CVM GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-185-vich-gl43-target-animal-safety-for-veterinary-pharmaceutical-products/d942db43-d174-4bef-aa05-d4a27a1c1301)
- [CVM GFI #183 Animal Drug User Fees: Fees Exceed Costs Waiver/Reduction](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-183-animal-drug-user-fees-fees-exceed-costs-waiverreduction/3661d690-1900-46d0-b667-e685213e3d17)